• Profile
Close

Comparative effects of low-dose vs standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial

Journal of the Neurological Sciences Jan 17, 2018

Chen G, et al. - The objective of this trial was to determine if a history of prior stroke (PS) and diabetes mellitus (DM) modified the comparative effects of low- vs standard-dose alteplase in patients enrolled into the alteplase-dose arm of the Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED). It was deduced that a history of PS and DM did not serve as an independent predictor of poor outcome in thrombolysis-treated acute ischemic stroke (AIS) patients. These variables did not cause any modification in the differences with regard to the effects of low- vs standard-dose alteplase.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay